evenfolioETF Details
Invesco·Health·IBBQ · Nasdaq
Invesco Nasdaq Biotechnology ETF (IBBQ)
- Price
- $36.17
- —30 Oct 2026
- Assets
- $103.3M
- Total net assets
- Expense ratio
- 0.19%
- Category 1.00%
- Yield
- 1.11%
- Trailing distributions
- 1Y return
- 38.6%+9.8%
- Category 28.8%
- 3Y CAGR
- 26.7%+5.1%
- Category 21.5%
- 5Y CAGR
- 8.7%+4.6%
- Category 4.1%
Loading NAV history…
Invesco Nasdaq Biotechnology ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +2.9% | +13.4% | +26.4% | +28.5% | +38.6% | +26.7% | +8.7% | — | +7.7% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -0.7% | +3.5% | +3.4% | +8.1% | +9.8% | +5.1% | +4.6% | — | -3.9% |
Holdings
The 10 largest positions make up 45.4% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| GILD | Gilead Sciences Inc | 8.16% |
| AMGN | Amgen Inc | 7.86% |
| VRTX | Vertex Pharmaceuticals Inc | 7.69% |
| MRNA | Moderna Inc | 5.04% |
| REGN | Regeneron Pharmaceuticals Inc | 5.02% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.88% |
| ILMN | Illumina Inc | 2.71% |
| BIIB | Biogen Inc | 2.19% |
| ALNY | Alnylam Pharmaceuticals Inc | 2.16% |
| ROIV | Roivant Sciences Ltd Ordinary Shares | 1.73% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.4
- P/S
- 6.7
- P/CF
- 17.7
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- Invesco
- Category
- Equity · Health
- Ticker
- IBBQ
- Exchange
- Nasdaq
- Inception
- 11 Jun 2021 (5.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.19% (category 1.00%)
- Holdings turnover
- 17% (category 51%)
- Distribution yield
- 1.11%
- Beta, 3 years
- 0.63
- Total net assets
- $103.3M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- GNOM · Global X Genomics & Biotechnology ETFGlobal X Funds · $102.9M · ER 0.50%5Y -3.8%
- AGNG · Global X Aging Population ETFGlobal X Funds · $88.9M · ER 0.50%5Y 6.8%
- HTEC · ROBO Global Healthcare Technology and Innovation ETFRobo Global · $76.3M · ER 0.68%5Y -0.3%
- OZEM · Roundhill GLP-1 & Weight Loss ETFRoundhill Investments · $57.8M · ER 0.59%
- HRTS · Tema Heart & Health ETFTema ETFs · $53.7M · ER 0.75%
- FMED · Fidelity Disruptive Medicine ETFFidelity Investments · $52.3M · ER 0.50%